Important News
Prior Review Updates - effective 3/01/2012
Criteria for coverage of Growth Hormones (somatropin) will include use of Omnitrope prior to all other growth hormones on the market
Change in Prior Review for Growth Hormones for ALL users
Coverage for Disease Modifying Drugs for MS: interferon beta (Extavia, Avonex ) will be updated. Betaseron will be preferred over Extavia and Rebif will be preferred over Avonex for NEW users
Tesamorelin will require prior review/certification for ALL users
Prior Review Required for tesamorelin (Egrifta®) for ALL users
BCBSNC is changing the administrative process regarding coverage of Renin Inhibitors for NEW users
Prior Review Required for Renin Inhibitors for NEW users